<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nephrourol Mon</journal-id><journal-id journal-id-type="iso-abbrev">Nephrourol Mon</journal-id><journal-id journal-id-type="doi">10.5812/numonthly</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Nephro-urology Monthly</journal-title></journal-title-group><issn pub-type="ppub">2251-7006</issn><issn pub-type="epub">2251-7014</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24719806</article-id><article-id pub-id-type="pmc">3968960</article-id><article-id pub-id-type="doi">10.5812/numonthly.13351</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Biniaz</surname><given-names>Vajihe</given-names></name><xref ref-type="aff" rid="aff25793">1</xref></contrib><contrib contrib-type="author"><name><surname>Sadeghi Shermeh</surname><given-names>Mehdi</given-names></name><xref ref-type="aff" rid="aff25794">2</xref></contrib><contrib contrib-type="author"><name><surname>Ebadi</surname><given-names>Abbas</given-names></name><xref ref-type="aff" rid="aff25794">2</xref></contrib><contrib contrib-type="author"><name><surname>Tayebi</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="aff25794">2</xref><xref ref-type="corresp" rid="cor25802">*</xref></contrib><contrib contrib-type="author"><name><surname>Einollahi</surname><given-names>Behzad</given-names></name><xref ref-type="aff" rid="aff25793">1</xref></contrib></contrib-group><aff id="aff25793"><label>1</label>Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff25794"><label>2</label>Department of Medical Surgical Nursing, Baqiyatallah University of Medical Sciences, Tehran, IR Iran</aff><author-notes><corresp id="cor25802"><label>*</label>Corresponding author: Ali Tayebi, Department of Medical Surgical Nursing, Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Tel: +98-9121058516, Fax: +98-2126127253, E-mail: <email>Tayybi.Ali@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>11</month><year>2013</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2014</year></pub-date><volume>6</volume><issue>1</issue><elocation-id>e13351</elocation-id><history><date date-type="received"><day>03</day><month>7</month><year>2013</year></date><date date-type="rev-recd"><day>14</day><month>7</month><year>2013</year></date><date date-type="accepted"><day>03</day><month>8</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014, Nephrology and Urology Research Center; Published by Kowsar Corp.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Chronic inflammation is the most important cause of cardiovascular disease in patients undergoing hemodialysis, and vitamin C as a major antioxidant which could be effective to suppress inflammation.</p></sec><sec><title>Objectives:</title><p>This study was performed to evaluate the effect of vitamin C supplementation on C-reactive protein levels in patients undergoing hemodialysis.</p></sec><sec><title>Patients and Methods:</title><p>This randomized, placebo-controlled and double-blind trial was conducted on 151 patients on hemodialysis who were divided randomly by lottery method to three identical groups. In the intervention group, 250 mg of vitamin C was injected intravenously immediately at the end of each hemodialysis session three times a week for 8 weeks in a row. In the control group 1, same term of placebo saline was injected, and in the control group 2, no intervention was performed.</p></sec><sec><title>Results:</title><p>A total of 86 (61%) male and 55 female patients with mean hemodialysis duration of 39.74 &#x000b1; 45.5 months, and a mean age of 61.36 &#x000b1; 11.46 years-old, participated in this study. Hypertension and diabetes were the most common underlying diseases (79.4%). Median baseline CRP in the intervention, control 1 and control 2 groups were 16.8, 17.8, and 19.4 mg/L respectively. After 2 months, median CRP reduced significantly in the vitamin C group to 10.7 (P = 0.04) vs. 22.6, and 30.6 mg/L in control groups.</p></sec><sec><title>Conclusions:</title><p>Our findings demonstrated that vitamin C supplementation modifies the levels of CRP in patients on hemodialysis.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Renal Insufficiency, Chronic</kwd><kwd>Renal Dialysis</kwd><kwd>C- Reactive Protein</kwd><kwd>Ascorbic Acid</kwd></kwd-group></article-meta></front><body><sec id="sec35263"><title>1. Background</title><p>End-stage renal disease (ESRD) is one of the most common chronic diseases (<xref rid="A13351R1" ref-type="bibr">1</xref>), and a major healthcare problem specifically in developing countries (<xref rid="A13351R2" ref-type="bibr">2</xref>). It is reported that the incidence and prevalence of ESRD are on the rise (<xref rid="A13351R3" ref-type="bibr">3</xref>). Although patients undergoing hemodialysis, as a maintenance invasive treatment, can live longer (<xref rid="A13351R4" ref-type="bibr">4</xref>), they experience diverse complications that noticeably disturb their quality of life (<xref rid="A13351R5" ref-type="bibr">5</xref>). According to data, mortality in patients on hemodialysis is almost 9-20 times more than the general population (<xref rid="A13351R6" ref-type="bibr">6</xref>), and mainly occurs due to atherosclerotic cardiovascular events (<xref rid="A13351R7" ref-type="bibr">7</xref>).</p><p>Chronic inflammation, a common disorder in patients on hemodialysis (<xref rid="A13351R8" ref-type="bibr">8</xref>) which represented by increased C-reactive protein (<xref rid="A13351R9" ref-type="bibr">9</xref>), is the most important cause of cardiovascular disease (<xref rid="A13351R10" ref-type="bibr">10</xref>-<xref rid="A13351R12" ref-type="bibr">12</xref>), and severely linked with morbidity and mortality in these patients (<xref rid="A13351R13" ref-type="bibr">13</xref>, <xref rid="A13351R14" ref-type="bibr">14</xref>). Although inflammation etiology in patients undergoing hemodialysis is varied (<xref rid="A13351R15" ref-type="bibr">15</xref>), they put on show the highest level of inflammation likely due to hidden infection associated with arteriovenous fistula or central venous catheters (<xref rid="A13351R16" ref-type="bibr">16</xref>), confrontation with endotoxin, and other pollutants and bioincompatible dialysis solution and membrane (<xref rid="A13351R17" ref-type="bibr">17</xref>).</p><p>C-reactive protein (CRP) is a major biomarker of inflammation and a mediator of atherosclerosis (<xref rid="A13351R18" ref-type="bibr">18</xref>). Serum level of CRP increases predominantly during inflammatory processes (<xref rid="A13351R19" ref-type="bibr">19</xref>), and is elevated in a large proportion of patients on hemodialysis (<xref rid="A13351R20" ref-type="bibr">20</xref>).</p><p>There is plenty evidence indicating the predictive value of CRP as a potent and strong independent risk marker for cardiovascular disease (CVD), and its morbidity and mortality (<xref rid="A13351R21" ref-type="bibr">21</xref>). Based on these findings, the determination of CRP level and its management as a main marker of inflammatory status of patients undergoing hemodialysis might help to pick out individuals with an high atherothrombotic risk (<xref rid="A13351R22" ref-type="bibr">22</xref>), and lead to improved outcomes (<xref rid="A13351R23" ref-type="bibr">23</xref>).</p><p>Since elevated oxidative stress plays a basic role in inflammation production due to the release of inflammatory mediators (<xref rid="A13351R24" ref-type="bibr">24</xref>), and increases free radicals associated with lessening production of essential antioxidants (<xref rid="A13351R25" ref-type="bibr">25</xref>) in patients on hemodialysis, vitamin C (ascorbic acid) could be effective as a major antioxidant in inflammation diminution (<xref rid="A13351R26" ref-type="bibr">26</xref>).</p><p>The antioxidant function of ascorbic acid, which is a water-soluble vitamin in human plasma, has been extensively studied in individuals with and without kidney failure (<xref rid="A13351R27" ref-type="bibr">27</xref>). Vitamin C deficiency is a prevalent complication in patients undergoing hemodialysis (<xref rid="A13351R28" ref-type="bibr">28</xref>-<xref rid="A13351R30" ref-type="bibr">30</xref>), and an important risk factor for increased inflammatory status (<xref rid="A13351R24" ref-type="bibr">24</xref>), cardiovascular disease and its mortality, occurs mainly due to loss of the vitamin during dialysis sessions, and dietary restriction of fresh fruits and vegetables to avoid hyperkalemia (<xref rid="A13351R31" ref-type="bibr">31</xref>).</p></sec><sec id="sec35264"><title>2. Objectives</title><p>Hitherto, different methods have been tested to treat elevated CRP in patients undergoing hemodialysis, but existing data on the effect of vitamin C on serum level of CRP is insufficient and had conflicting results (<xref rid="A13351R32" ref-type="bibr">32</xref>-<xref rid="A13351R34" ref-type="bibr">34</xref>). This study was performed to evaluate whether vitamin C supplementation could modify CRP levels in patients undergoing hemodialysis.</p></sec><sec id="sec35265"><title>3. Patients and Methods</title><p>This randomized, placebo-controlled and double-blind trial was conducted from October 2012 to January 2013 on 151 patients with ESRD undergoing maintenance dialysis in two hemodialysis units in Baqiyatallah and Chamran hospitals of Tehran, Iran. They were randomly distributed by lottery method into three identical groups (simple random sampling); intervention group received vitamin C, control group 1 received placebo, and control group 2 received no intervention. Qualification was not limited to patients with elevated CRP. The sampling frame included all patients with ESRD aged equal or older than 18 years, regular recourse for hemodialysis of three sessions per week, receiving hemodialysis &#x02265; 6 months, and not taking vitamin C or E at least from 3 months ago. Exclusion criteria included history of renal transplantation for less than one year ago, using anti-inflammatory medications such as immunosuppressive agents, being infected by active infections, getting cancers, smoking and passive smoke exposure, and alcohol consumption.</p><p>Of 152 randomized patients, 10 were excluded from the study due to transmission to other dialysis centers, being infected by active infections, getting cancers, death, or their own refusal, and only 141 patients completed the study.</p><p>All groups were alike in clinical particulars including age, sex, weight, marital and employment status, length and session of hemodialysis and smoking. The length of dialysis in all of patients was approximately 4 hours, and its occasions were 3 times a week with resemble KT/V (it a scale used to assess&#x000a0;the adequacy of hemodialysis and peritoneal dialysis treatment). The KT/V did not change during the research.</p><p>Prior ethical approval was obtained from the institutional ethical committee at Baqiyatallah University of Medical Sciences, Tehran, Iran. A justification letter was sent to two hemodialysis units to gain permission to collect the data granted by these units. Oral and written consents were obtained from all those who participated in the study. Written consents were obtained after informing each participant about the study purposes, the &#x0201c;confidentiality&#x0201d; of their information, and the possibility to refuse the test procedure at any stage of it.</p><p>A demographic questionnaire was developed by the researcher to record age, gender, marital and education status, number of children, employment status, income, weight, smoking history, nephropathy cause, and length of time receiving dialysis. Serum levels of C-reactive protein were measured at the beginning, and at the end of the intervention.</p><p>In intervention group, 250 mg of vitamin C was injected intravenously immediately at the end of each hemodialysis session three times a week for 8 weeks in a row. In the control group 1, same term of placebo saline was injected, and in control group 2 no intervention was performed. Although the recommended amount for vitamin C intake in patients on hemodialysis is 100-200 mg per day (<xref rid="A13351R35" ref-type="bibr">35</xref>), only 250 mg of vitamin C three times a week, lower than the safe dosage recommended by NIH (<xref rid="A13351R28" ref-type="bibr">28</xref>) was prescribed to prevent oxalosis.</p><p>All data were shown as mean &#x000b1; SD. The X<sup>2</sup>-test, T-test and ANOVA were used in this study. The data was analyzed by SPSS software (version 18). The researcher decided to receive only a 5% error in rejecting the full hypothesis at the 95% confidence interval. The significance level was put at 0.05.</p></sec><sec id="sec35266"><title>4. Results</title><p>Complete data was gathered for 141 patients on hemodialysis (86 male, 55 female) with a mean age of 61.36 &#x000b1; 11.46 years, and mean hemodialysis duration of 39.74 &#x000b1; 45.5 months. There was no significant association between age and duration on hemodialysis with CRP levels by using independent sample t-test.</p><p>The most common etiology of nephropathy was hypertension (38.3% hypertension, and 26.2% hypertension and DM simultaneously). The highest mean CRP level was seen in individuals with hypertension, but there was no significant correlation between nephropathy causes and CRP levels.</p><p>The mean duration of dialysis sessions was 3.8 h. All groups, with and without vitamin C supplementation, were similar in sex proportion, age, main clinical characteristics, and mean time on hemodialysis. Educational level was primary-secondary in 51.8% of participants. There was no significant correlation between educational level and serum CRP levels. Additional demographic characteristics of different groups&#x02019; patients according to variable kind are shown in <xref ref-type="table" rid="tbl9205">Tables 1</xref> and <xref ref-type="table" rid="tbl9207">2</xref>. </p><p>CRP &#x0003e; 6 and CRP &#x0003e; 10 mg/L were observed in 41.1% and 34.8% of the patients, respectively. Median baseline CRP in the case, control 1 and control 2 groups were 16.8, 17.8, and 19.4 mg/L respectively. As seen in <xref ref-type="table" rid="tbl9206">Table 3</xref>, patients of the three groups did not have any significant difference regarding serum level of CRP at baseline. After 2 months, median CRP reduced significantly in the vitamin C group to 10.7 (P = 0.04) vs. 22.6 and 30.6 mg/L in control groups. </p><table-wrap id="tbl9205" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Baseline Qualitative Characteristics of the Respondents </title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" style="text-align: left; vertical-align: top" colspan="1">Variables</th><th colspan="3" style="border-bottom:solid thin;" rowspan="1">Group</th><th rowspan="2" style="text-align: left; vertical-align: top" colspan="1">X<sup>2</sup>-test</th></tr><tr><th style="text-align: left" rowspan="1" colspan="1">Vitamin C, No. (%)</th><th style="text-align: left" rowspan="1" colspan="1">Placebo, No. (%)</th><th style="text-align: left" rowspan="1" colspan="1">Control, No. (%)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Gender</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">0.83</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">32 (22.7)</td><td rowspan="1" colspan="1">34 (24.1)</td><td rowspan="1" colspan="1">20 (14.2)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">23 (16.3)</td><td rowspan="1" colspan="1">21 (14.9)</td><td rowspan="1" colspan="1">11 (7.8)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Education</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">0.88</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Primary-secondary</td><td rowspan="1" colspan="1">29 (20.5)</td><td rowspan="1" colspan="1">30 (21.3)</td><td rowspan="1" colspan="1">14 (9.9)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">College/university-level</td><td rowspan="1" colspan="1">26(18.4)</td><td rowspan="1" colspan="1">25 (17.7)</td><td rowspan="1" colspan="1">17 (12.1)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Marital status</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">0.3</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Married</td><td rowspan="1" colspan="1">49 (34.8)</td><td rowspan="1" colspan="1">43 (30.5)</td><td rowspan="1" colspan="1">28 (19.9)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Single/widow</td><td rowspan="1" colspan="1">6 (4.3)</td><td rowspan="1" colspan="1">12 (8.5)</td><td rowspan="1" colspan="1">3 (2.1)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Employment</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">0.95</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Employed</td><td rowspan="1" colspan="1">4 (2.8)</td><td rowspan="1" colspan="1">3 (2.1)</td><td rowspan="1" colspan="1">3 (2.1)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Retired</td><td rowspan="1" colspan="1">28 (19.9)</td><td rowspan="1" colspan="1">32 (22.7)</td><td rowspan="1" colspan="1">17 (12.1)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Jobless/housekeeper</td><td rowspan="1" colspan="1">23 (16.3)</td><td rowspan="1" colspan="1">20 (14.2)</td><td rowspan="1" colspan="1">11 (7.8)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Smoking</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">0.45</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">1 (0.7)</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">54 (38.3)</td><td rowspan="1" colspan="1">55 (39)</td><td rowspan="1" colspan="1">31 (22)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">
<bold>Nephropathy cause</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">0.2</td></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">HTN<sup><xref ref-type="table-fn" rid="fn5996">a</xref></sup></td><td rowspan="1" colspan="1">19 (13.5)</td><td rowspan="1" colspan="1">20 (14.2)</td><td rowspan="1" colspan="1">12 (8.5)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">DM<sup><xref ref-type="table-fn" rid="fn5996">a</xref></sup></td><td rowspan="1" colspan="1">5 (3.5)</td><td rowspan="1" colspan="1">7 (5)</td><td rowspan="1" colspan="1">8 (5.7)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">HTN and DM</td><td rowspan="1" colspan="1">17 (12.1)</td><td rowspan="1" colspan="1">16 (11.3)</td><td rowspan="1" colspan="1">8 (5.7)</td><td rowspan="1" colspan="1"/></tr><tr><td style="padding-left: 20pt;" rowspan="1" colspan="1">Others</td><td rowspan="1" colspan="1">14 (9.9)</td><td rowspan="1" colspan="1">12 (8.5)</td><td rowspan="1" colspan="1">3 (2.1)</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="fn5996"><p><sup>a</sup> Abbreviations: DM, diabetes mellitus; HTN, hypertention.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl9207" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Baseline Quantitative Characteristics of the Respondents </title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" style="text-align: left; vertical-align: top" colspan="1">Variables</th><th colspan="3" style="border-bottom:solid thin;" rowspan="1">Group</th><th rowspan="2" style="text-align: left; vertical-align: top" colspan="1">ANOVA</th></tr><tr><th style="text-align: left" rowspan="1" colspan="1">Vitamin C, Mean &#x000b1; SD</th><th style="text-align: left" rowspan="1" colspan="1">Placebo, Mean &#x000b1; SD</th><th style="text-align: left" rowspan="1" colspan="1">Control, Mean &#x000b1; SD</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>Age, y</bold>
</td><td rowspan="1" colspan="1">59.4 &#x000b1; 11.8</td><td rowspan="1" colspan="1">62.75 &#x000b1; 10.85</td><td rowspan="1" colspan="1">62.39 &#x000b1; 11.77</td><td rowspan="1" colspan="1">0.26</td></tr><tr><td rowspan="1" colspan="1">
<bold>Dialysis vintage, mo</bold>
</td><td rowspan="1" colspan="1">47.69 &#x000b1; 45.7</td><td rowspan="1" colspan="1">32.83 &#x000b1; 26.51</td><td rowspan="1" colspan="1">34.45 &#x000b1; 34.47</td><td rowspan="1" colspan="1">0.08</td></tr><tr><td rowspan="1" colspan="1">
<bold>Body weight, Kg</bold>
</td><td rowspan="1" colspan="1">68.2 &#x000b1; 11.87</td><td rowspan="1" colspan="1">71.8 &#x000b1; 13.33</td><td rowspan="1" colspan="1">67.8 &#x000b1; 10.69</td><td rowspan="1" colspan="1">0.21</td></tr></tbody></table></table-wrap><table-wrap id="tbl9206" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Variables Alterations in Different Stages of Study </title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" style="text-align: left; vertical-align: top" colspan="1">Variable</th><th rowspan="2" style="text-align: left; vertical-align: top" colspan="1">Time</th><th colspan="3" style="border-bottom:solid thin;" rowspan="1">Group</th><th rowspan="2" style="text-align: left; vertical-align: top" colspan="1">ANOVA</th></tr><tr><th style="text-align: left" rowspan="1" colspan="1">Vitamin C, Mean &#x000b1; SD</th><th style="text-align: left" rowspan="1" colspan="1">Placebo, Mean &#x000b1; SD</th><th style="text-align: left" rowspan="1" colspan="1">Control, Mean &#x000b1; SD</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<bold>CRP levels</bold>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">16.84 &#x000b1; 27.9</td><td rowspan="1" colspan="1">17.79 &#x000b1; 27.6</td><td rowspan="1" colspan="1">19.4 &#x000b1; 26.7</td><td rowspan="1" colspan="1">0.92</td></tr><tr><td rowspan="1" colspan="1"/><td style="vertical-align: middle;" rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">10.78 &#x000b1; 25.4</td><td rowspan="1" colspan="1">22.66 &#x000b1; 38.5</td><td rowspan="1" colspan="1">30.66 &#x000b1; 46.4</td><td rowspan="1" colspan="1">0.04</td></tr></tbody></table></table-wrap></sec><sec id="sec35267"><title>5. Discussion</title><p>Our findings demonstrated that vitamin C supplementation modifies the levels of CRP in patients undergoing hemodialysis. Results of the present study were in accordance and supported by earlier studies such as Block (<xref rid="A13351R36" ref-type="bibr">36</xref>), and Gholipour (<xref rid="A13351R37" ref-type="bibr">37</xref>), but these findings were contrary with Fumeron study (<xref rid="A13351R38" ref-type="bibr">38</xref>). He suggested that oral vitamin C cannot modify the levels of CRP in patients undergoing hemodialysis. One possible explanation for the lack of effectiveness of supplementation with oral vitamin C in modifying the levels of CRP in patients undergoing hemodialysis could be related to the route of vitamin C prescription (oral vs. intravenous), so that could foresee higher plasma vitamin C concentrations in patients on hemodialysis after intravenous prescription. According to data intravenous prescription increases serum level of vitamin C more than similar doses of oral vitamin C (<xref rid="A13351R39" ref-type="bibr">39</xref>), and this increased serum level is extremely associated with lessen oxidative stress and CRP levels (<xref rid="A13351R40" ref-type="bibr">40</xref>). Also, small sample size (33 people) and no usage of placebo, randomization, and control group in Fumeron study could be other reasons for it. Consistent with earlier literature, our study indicated that hypertension and diabetes were the most common causes of nephropathy (hypertension and diabetes 79.4%).</p><p>Unlike findings from some studies, in which more than 50% of patients on hemodialysis were jobless, our data suggested that 61.7% of participants were retired or employed, and only 4.3% were unemployed. This could indicate that the government and insurance companies have an appropriate support of patients on hemodialysis in Iran.</p><p>Although results of Helal study showed that there was a significant correlation between age above 40 years and more than 5 years duration on hemodialysis with serum hs-CRP (<xref rid="A13351R41" ref-type="bibr">41</xref>), in this study an independent samples t-test confirmed that there was no significant association between CRP level with age and duration on hemodialysis.</p><p>According to data, the incidence of CKD is higher in men and people older than 45 years. In the present study, while the mean age of patients was 61.36 (SD 11.46) years, most of them (61%) were male, and 91.5% were older than 45 years. </p><p>Patients on hemodialysis are at risk for low levels of serum vitamin C (<xref rid="A13351R42" ref-type="bibr">42</xref>, <xref rid="A13351R43" ref-type="bibr">43</xref>). Vitamin C is a water-soluble vitamin which can be reduced by regular hemodialysis (<xref rid="A13351R44" ref-type="bibr">44</xref>). Dietary restrictions following fear related to hyperkalemia (<xref rid="A13351R45" ref-type="bibr">45</xref>), concern oxalosis, wasting several hundred mg of vitamin C during one session of hemodialysis (<xref rid="A13351R46" ref-type="bibr">46</xref>), and fast catabolism lead to vitamin C deficiency in patients on hemodialysis. Although normal range of serum vitamin C is 30-60 &#x003bc;M, most patients undergoing hemodialysis have serum levels of vitamin C less than 10 &#x003bc;M, and even some of them have less than 2 &#x003bc;M (<xref rid="A13351R47" ref-type="bibr">47</xref>). Moreover, chronic inflammation due to the release of inflammatory mediators in patients on hemodialysis leads to reduced production of essential antioxidants and increased oxidative stress (<xref rid="A13351R26" ref-type="bibr">26</xref>), and it increases free radicals associated with vitamin C deficiency as an important antioxidant (<xref rid="A13351R25" ref-type="bibr">25</xref>). Therefore vitamin C deficiency may play an important role in increased inflammatory status in these patients.</p><p>Even if 60 to 100 mg of vitamin C in an individual with normal kidney function is sufficient for health maintenance, it may not be adequate in a patient on hemodialysis due to the mentioned reasons. The recommended amounts for vitamin C in patients undergoing hemodialysis are 100-200 mg per day, which almost none of patients on hemodialysis consume (<xref rid="A13351R48" ref-type="bibr">48</xref>).</p><p>Albeit existing data about the effect of vitamin C on CRP levels in patients on hemodialysis were contradictory, our data confirmed that there was a reverse association between serum levels of vitamin C and CRP (<xref rid="A13351R49" ref-type="bibr">49</xref>, <xref rid="A13351R50" ref-type="bibr">50</xref>). CRP levels decreased more obviously in intervention group who received supplemental vitamin C than the control group (P = 0.028). But no significant difference in CRP levels was observed between the placebo and witness groups.</p><p>Not measuring plasma levels of vitamin C before, and after the study, and not specifying the patients who had vitamin C deficiency before the study were the limitations in our study which burden the ability to generalize the findings. Removing these limitations was not a feasible option due to the financial costs, and the limitations of laboratories capable of providing the circumstance for this test. It is recommended to perform studies with longer-term use of vitamin C, and larger sample sizes.</p><p>Conclusions: Our findings demonstrated that there was a reverse relation between supplemental vitamin C and CRP levels, and vitamin C supplementation could modify the levels of CRP in patients on hemodialysis. Serial determinations of CRP are more effective for a better prediction of the inflammatory state of patients on chronic hemodialysis than scattered single time-point measurements. Vitamin C supplementation with its CRP-lowering effect could be a simple and useful method in modifying inflammation status, and a potential goal for reducing cardiovascular disease risk in patients on hemodialysis. Therefore, further investigations with longer-term use of vitamin C and larger sample sizes are recommended.</p></sec></body><back><ack><p>The present article was a part of a master degree thesis supported by Baqiyatallah University of Medical Sciences. This project was supported by a grant from Nephrology and Urology Research Center of Baqiyatallah University of Medical Sciences. Authors gratefully acknowledge the assistance of all participants and nurses of Baqiyatallah and Shahid Chamran hospitals.</p></ack><fn-group><fn id="afn20066" fn-type="other"><p><bold>Implication for health policy/practice/research/medical education:</bold>Vitamin C supplementation with its CRP-lowering effect could be a simple anduseful method in modifying inflammation status, and a potential goal for reducingcardiovascular disease risk in patients undergoing hemodialysis.</p></fn><fn id="afn20067" fn-type="other"><p><bold>Authors&#x02019; Contribution:</bold>Vajihe Biniaz developed the protocol, abstracted analyzed and interpreted data, wrote and prepared the manuscript, and revised the manuscript for demanded reforms. Ali Tayebi contributed to the development of the protocol and was the corresponding author. Abbas Ebadi contributed to the data analyze and the manuscript revision. Mehdi Sadeghi and Behzad Einollahi contributed to development of the protocol.</p></fn><fn id="afn20068" fn-type="other"><p><bold>Financial Disclosure:</bold>There was no conflict of interest.</p></fn><fn id="afn20069" fn-type="other"><p><bold>Funding Support:</bold>This project was supported by a grant from Nephrology and Urology Research Center of Baqiyatallah University of Medical Sciences.</p></fn></fn-group><ref-list><title>References</title><ref id="A13351R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castner</surname><given-names>D</given-names></name></person-group><article-title>Understanding the stages of chronic kidney disease.</article-title><source>Nursing.</source><year>2010</year><volume>40</volume><issue>5</issue><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1097/01.NURSE.0000371121.30888.0e</pub-id><pub-id pub-id-type="pmid">20386393</pub-id></element-citation></ref><ref id="A13351R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinpanah</surname><given-names>F</given-names></name><name><surname>Kasraei</surname><given-names>F</given-names></name><name><surname>Nassiri</surname><given-names>AA</given-names></name><name><surname>Azizi</surname><given-names>F</given-names></name></person-group><article-title>High prevalence of chronic kidney disease in Iran: a large population-based study.</article-title><source>BMC Public Health.</source><year>2009</year><volume>9</volume><issue>44</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/1471-2458-9-44</pub-id><pub-id pub-id-type="pmid">19121216</pub-id></element-citation></ref><ref id="A13351R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horigan</surname><given-names>AE</given-names></name></person-group><article-title>Fatigue in hemodialysis patients: a review of current knowledge.</article-title><source>J Pain Symptom Manage.</source><year>2012</year><volume>44</volume><issue>5</issue><fpage>715</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.jpainsymman.2011.10.015</pub-id><pub-id pub-id-type="pmid">22743156</pub-id></element-citation></ref><ref id="A13351R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letchmi</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Halim</surname><given-names>H</given-names></name><name><surname>Zakariah</surname><given-names>FA</given-names></name><name><surname>Hassan</surname><given-names>H</given-names></name><name><surname>Mat</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Fatigue experienced by patients receiving maintenance dialysis in hemodialysis units.</article-title><source>Nurs Health Sci.</source><year>2011</year><volume>13</volume><issue>1</issue><fpage>60</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1111/j.1442-2018.2011.00579.x</pub-id><pub-id pub-id-type="pmid">21392194</pub-id></element-citation></ref><ref id="A13351R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleary</surname><given-names>J</given-names></name><name><surname>Drennan</surname><given-names>J</given-names></name></person-group><article-title>Quality of life of patients on haemodialysis for end-stage renal disease.</article-title><source>J Adv Nurs.</source><year>2005</year><volume>51</volume><issue>6</issue><fpage>577</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2648.2005.03547.x</pub-id><pub-id pub-id-type="pmid">16129008</pub-id></element-citation></ref><ref id="A13351R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdollahzad</surname><given-names>H</given-names></name><name><surname>Eghtesadi</surname><given-names>SH</given-names></name><name><surname>Noormohammadi</surname><given-names>E</given-names></name><name><surname>Khadem Ansari</surname><given-names>MH</given-names></name><name><surname>Nejadghashti</surname><given-names>H</given-names></name><name><surname>Esmaeilzadeh</surname><given-names>A</given-names></name></person-group><article-title>[Effect of vitamin C supplementation on oxidative stress in hemodialysis patients].</article-title><source>Urumia Med J.</source><year>2007</year><volume>18</volume><issue>2</issue><fpage>490</fpage><lpage>7</lpage></element-citation></ref><ref id="A13351R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepys</surname><given-names>MB</given-names></name><name><surname>Hirschfield</surname><given-names>GM</given-names></name></person-group><article-title>C-reactive protein: a critical update.</article-title><source>J Clin Invest.</source><year>2003</year><volume>111</volume><issue>12</issue><fpage>1805</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1172/JCI18921</pub-id><pub-id pub-id-type="pmid">12813013</pub-id></element-citation></ref><ref id="A13351R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiedler</surname><given-names>R</given-names></name><name><surname>Neugebauer</surname><given-names>F</given-names></name><name><surname>Ulrich</surname><given-names>C</given-names></name><name><surname>Wienke</surname><given-names>A</given-names></name><name><surname>Gromann</surname><given-names>C</given-names></name><name><surname>Storr</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.</article-title><source>Artif Organs.</source><year>2012</year><volume>36</volume><issue>10</issue><fpage>886</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1111/j.1525-1594.2012.01479.x</pub-id><pub-id pub-id-type="pmid">22845695</pub-id></element-citation></ref><ref id="A13351R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krane</surname><given-names>V</given-names></name><name><surname>Winkler</surname><given-names>K</given-names></name><name><surname>Drechsler</surname><given-names>C</given-names></name><name><surname>Lilienthal</surname><given-names>J</given-names></name><name><surname>Marz</surname><given-names>W</given-names></name><name><surname>Wanner</surname><given-names>C</given-names></name></person-group><article-title>Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.</article-title><source>Am J Kidney Dis.</source><year>2009</year><volume>54</volume><issue>5</issue><fpage>902</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2009.06.029</pub-id><pub-id pub-id-type="pmid">19781835</pub-id></element-citation></ref><ref id="A13351R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marinelli</surname><given-names>A</given-names></name><name><surname>Orlandi</surname><given-names>L</given-names></name><name><surname>Stivali</surname><given-names>G</given-names></name></person-group><article-title>C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis.</article-title><source>Clin Nephrol.</source><year>2011</year><volume>76</volume><issue>6</issue><fpage>425</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">22105444</pub-id></element-citation></ref><ref id="A13351R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>C</given-names></name><name><surname>Bosson</surname><given-names>JL</given-names></name><name><surname>Pernod</surname><given-names>G</given-names></name><name><surname>Wauters</surname><given-names>JP</given-names></name><name><surname>Couturier</surname><given-names>P</given-names></name><name><surname>Quesada</surname><given-names>JL</given-names></name><etal>et al.</etal></person-group><article-title>Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology?</article-title><source>Aging Clin Exp Res.</source><year>2011</year><volume>23</volume><issue>5-6</issue><fpage>357</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">22526070</pub-id></element-citation></ref><ref id="A13351R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tayyebi-Khosroshahi</surname><given-names>H</given-names></name><name><surname>Houshyar</surname><given-names>J</given-names></name><name><surname>Dehgan-Hesari</surname><given-names>R</given-names></name><name><surname>Alikhah</surname><given-names>H</given-names></name><name><surname>Vatankhah</surname><given-names>AM</given-names></name><name><surname>Safaeian</surname><given-names>AR</given-names></name><etal>et al.</etal></person-group><article-title>Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.</article-title><source>Saudi J Kidney Dis Transpl.</source><year>2012</year><volume>23</volume><issue>3</issue><fpage>500</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22569435</pub-id></element-citation></ref><ref id="A13351R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amemiya</surname><given-names>N</given-names></name><name><surname>Ogawa</surname><given-names>T</given-names></name><name><surname>Otsuka</surname><given-names>K</given-names></name><name><surname>Ando</surname><given-names>Y</given-names></name><name><surname>Nitta</surname><given-names>K</given-names></name></person-group><article-title>Comparison of serum albumin, serum C-reactive protein, and pulse wave velocity as predictors of the 4-year mortality of chronic hemodialysis patients.</article-title><source>J Atheroscler Thromb.</source><year>2011</year><volume>18</volume><issue>12</issue><fpage>1071</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21921415</pub-id></element-citation></ref><ref id="A13351R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>R</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Ishii</surname><given-names>H</given-names></name><name><surname>Kasuga</surname><given-names>H</given-names></name><name><surname>Mizuno</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Combined values of serum albumin, C-reactive protein and body mass index at dialysis initiation accurately predicts long-term mortality.</article-title><source>Am J Nephrol.</source><year>2012</year><volume>36</volume><issue>2</issue><fpage>136</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1159/000339940</pub-id><pub-id pub-id-type="pmid">22813921</pub-id></element-citation></ref><ref id="A13351R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Espinoza</surname><given-names>L</given-names></name><name><surname>Rojas-Campos</surname><given-names>E</given-names></name><name><surname>Medina-Perez</surname><given-names>M</given-names></name><name><surname>Pena-Quintero</surname><given-names>P</given-names></name><name><surname>Gomez-Navarro</surname><given-names>B</given-names></name><name><surname>Cueto-Manzano</surname><given-names>AM</given-names></name></person-group><article-title>Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.</article-title><source>Nephrol Dial Transplant.</source><year>2012</year><volume>27</volume><issue>5</issue><fpage>2023</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfr579</pub-id><pub-id pub-id-type="pmid">21968012</pub-id></element-citation></ref><ref id="A13351R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Saran</surname><given-names>K</given-names></name><name><surname>Sabry</surname><given-names>A</given-names></name><name><surname>Shalaby</surname><given-names>M</given-names></name><name><surname>Al Sherbeiny</surname><given-names>S</given-names></name><name><surname>Abdelkader</surname><given-names>M</given-names></name></person-group><article-title>Level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with non-infected catheters and arteriovenous fistula in a large Saudi hemodialysis center.</article-title><source>Ther Apher Dial.</source><year>2013</year><volume>17</volume><issue>1</issue><fpage>35</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1744-9987.2012.01116.x</pub-id><pub-id pub-id-type="pmid">23379491</pub-id></element-citation></ref><ref id="A13351R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidt</surname><given-names>DG</given-names></name></person-group><article-title>Inflammation in renal disease.</article-title><source>Am J Cardiol.</source><year>2006</year><volume>97</volume><issue>2A</issue><fpage>20A</fpage><lpage>7A</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2005.11.012</pub-id><pub-id pub-id-type="pmid">16442933</pub-id></element-citation></ref><ref id="A13351R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Rose</surname><given-names>L</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name></person-group><article-title>Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.</article-title><source>N Engl J Med.</source><year>2002</year><volume>347</volume><issue>20</issue><fpage>1557</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa021993</pub-id><pub-id pub-id-type="pmid">12432042</pub-id></element-citation></ref><ref id="A13351R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razeghi</surname><given-names>E</given-names></name><name><surname>Lessan Pezeshki</surname><given-names>M</given-names></name><name><surname>Aazaripour</surname><given-names>A</given-names></name></person-group><article-title>[Evaluation of variability of acute phase proteins in hemodialysis patients].</article-title><source>Tehran Univ Med J.</source><year>2006</year><volume>64</volume><issue>9</issue><fpage>78</fpage><lpage>82</lpage></element-citation></ref><ref id="A13351R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baradari</surname><given-names>AG</given-names></name><name><surname>Emami Zeydi</surname><given-names>A</given-names></name><name><surname>Espahbodi</surname><given-names>F</given-names></name><name><surname>Shahmohammadi</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of serum C-reactive protein level and its related factors in hemodialysis patients in Sari, Iran.</article-title><source>Pak J Biol Sci.</source><year>2011</year><volume>14</volume><issue>10</issue><fpage>595</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22097096</pub-id></element-citation></ref><ref id="A13351R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanner</surname><given-names>C</given-names></name><name><surname>Metzger</surname><given-names>T</given-names></name></person-group><article-title>C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.</article-title><source>Nephrol Dial Transplant.</source><year>2002</year><volume>17 Suppl 8</volume><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">12147774</pub-id></element-citation></ref><ref id="A13351R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><article-title>High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.</article-title><source>Am Heart J.</source><year>2004</year><volume>148</volume><issue>1 Suppl</issue><fpage>S19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2004.04.028</pub-id><pub-id pub-id-type="pmid">15211329</pub-id></element-citation></ref><ref id="A13351R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazeley</surname><given-names>J</given-names></name><name><surname>Bieber</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Morgenstern</surname><given-names>H</given-names></name><name><surname>de Sequera</surname><given-names>P</given-names></name><name><surname>Combe</surname><given-names>C</given-names></name><etal>et al.</etal></person-group><article-title>C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients.</article-title><source>Clin J Am Soc Nephrol.</source><year>2011</year><volume>6</volume><issue>10</issue><fpage>2452</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.2215/CJN.00710111</pub-id><pub-id pub-id-type="pmid">21868617</pub-id></element-citation></ref><ref id="A13351R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Zuo</surname><given-names>L</given-names></name></person-group><article-title>Low levels of vitamin C in dialysis patients is associated with decreased prealbumin and increased C-reactive protein.</article-title><source>BMC Nephrol.</source><year>2011</year><volume>12</volume><issue>18</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/1471-2369-12-18</pub-id><pub-id pub-id-type="pmid">21235763</pub-id></element-citation></ref><ref id="A13351R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissinger</surname><given-names>EM</given-names></name><name><surname>Nguyen-Khoa</surname><given-names>T</given-names></name><name><surname>Fumeron</surname><given-names>C</given-names></name><name><surname>Saltiel</surname><given-names>C</given-names></name><name><surname>Walden</surname><given-names>M</given-names></name><name><surname>Kaiser</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment.</article-title><source>Proteomics.</source><year>2006</year><volume>6</volume><issue>3</issue><fpage>993</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1002/pmic.200500210</pub-id><pub-id pub-id-type="pmid">16372263</pub-id></element-citation></ref><ref id="A13351R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farsi</surname><given-names>Z</given-names></name></person-group><article-title>Effect of stress oxidative on kidney disease.</article-title><source>J Baqiyatallah Univ Med Sci.</source><year>2008</year><volume>27</volume><fpage>22</fpage><lpage>3</lpage></element-citation></ref><ref id="A13351R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>LJ</given-names></name><name><surname>Traber</surname><given-names>MG</given-names></name><name><surname>Kobuchi</surname><given-names>H</given-names></name><name><surname>Matsugo</surname><given-names>S</given-names></name><name><surname>Tritschler</surname><given-names>HJ</given-names></name><name><surname>Packer</surname><given-names>L</given-names></name></person-group><article-title>Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation.</article-title><source>Arch Biochem Biophys.</source><year>1996</year><volume>327</volume><issue>2</issue><fpage>330</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1006/abbi.1996.0130</pub-id><pub-id pub-id-type="pmid">8619623</pub-id></element-citation></ref><ref id="A13351R28"><label>28</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Vitamin</surname><given-names>C</given-names></name></person-group><article-title>Dietary Supplement Fact Sheet: NIH Office of Dietary Supplements.</article-title><date-in-citation content-type="access-date">cited June 24, 2011</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://ods.od.nih.gov/factsheets/VitaminC-QuickFacts">http://ods.od.nih.gov/factsheets/VitaminC-QuickFacts</ext-link></comment></element-citation></ref><ref id="A13351R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coveney</surname><given-names>N</given-names></name><name><surname>Polkinghorne</surname><given-names>KR</given-names></name><name><surname>Linehan</surname><given-names>L</given-names></name><name><surname>Corradini</surname><given-names>A</given-names></name><name><surname>Kerr</surname><given-names>PG</given-names></name></person-group><article-title>Water-soluble vitamin levels in extended hours hemodialysis.</article-title><source>Hemodial Int.</source><year>2010</year><fpage>[Epub ahead of print]</fpage><pub-id pub-id-type="doi">10.1111/j.1542-4758.2010.00505.x</pub-id><pub-id pub-id-type="pmid">21105994</pub-id></element-citation></ref><ref id="A13351R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>Association between vitamin C deficiency and dialysis modalities.</article-title><source>Nephrology (Carlton).</source><year>2012</year><volume>17</volume><issue>5</issue><fpage>452</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1797.2012.01595.x</pub-id><pub-id pub-id-type="pmid">22404236</pub-id></element-citation></ref><ref id="A13351R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deicher</surname><given-names>R</given-names></name><name><surname>Ziai</surname><given-names>F</given-names></name><name><surname>Bieglmayer</surname><given-names>C</given-names></name><name><surname>Schillinger</surname><given-names>M</given-names></name><name><surname>Horl</surname><given-names>WH</given-names></name></person-group><article-title>Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.</article-title><source>J Am Soc Nephrol.</source><year>2005</year><volume>16</volume><issue>6</issue><fpage>1811</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1681/ASN.2004100850</pub-id><pub-id pub-id-type="pmid">15814831</pub-id></element-citation></ref><ref id="A13351R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Block</surname><given-names>G</given-names></name><name><surname>Jensen</surname><given-names>CD</given-names></name><name><surname>Dalvi</surname><given-names>TB</given-names></name><name><surname>Norkus</surname><given-names>EP</given-names></name><name><surname>Hudes</surname><given-names>M</given-names></name><name><surname>Crawford</surname><given-names>PB</given-names></name><etal>et al.</etal></person-group><article-title>Vitamin C treatment reduces elevated C-reactive protein.</article-title><source>Free Radic Biol Med.</source><year>2009</year><volume>46</volume><issue>1</issue><fpage>70</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.09.030</pub-id><pub-id pub-id-type="pmid">18952164</pub-id></element-citation></ref><ref id="A13351R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>E</given-names></name><name><surname>Sasazuki</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Tsubono</surname><given-names>Y</given-names></name><name><surname>Okubo</surname><given-names>S</given-names></name><name><surname>Tsugane</surname><given-names>S</given-names></name></person-group><article-title>Vitamin C supplementation in relation to inflammation in individuals with atrophic gastritis: a randomised controlled trial in Japan.</article-title><source>Br J Nutr.</source><year>2013</year><volume>109</volume><issue>6</issue><fpage>1089</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1017/S0007114512002954</pub-id><pub-id pub-id-type="pmid">23167953</pub-id></element-citation></ref><ref id="A13351R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Doherty</surname><given-names>MG</given-names></name><name><surname>Gilchrist</surname><given-names>SE</given-names></name><name><surname>Young</surname><given-names>IS</given-names></name><name><surname>McKinley</surname><given-names>MC</given-names></name><name><surname>Yarnell</surname><given-names>JW</given-names></name><name><surname>Gey</surname><given-names>KF</given-names></name><etal>et al.</etal></person-group><article-title>Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.</article-title><source>Eur J Nutr.</source><year>2010</year><volume>49</volume><issue>8</issue><fpage>483</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/s00394-010-0107-x</pub-id><pub-id pub-id-type="pmid">20401662</pub-id></element-citation></ref><ref id="A13351R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanadgol</surname><given-names>H</given-names></name><name><surname>Bayani</surname><given-names>M</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name><name><surname>Bayani</surname><given-names>B</given-names></name><name><surname>Mashhadi</surname><given-names>MA</given-names></name></person-group><article-title>Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.</article-title><source>Iran J Kidney Dis.</source><year>2011</year><volume>5</volume><issue>6</issue><fpage>410</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22057074</pub-id></element-citation></ref><ref id="A13351R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Block</surname><given-names>G</given-names></name><name><surname>Jensen</surname><given-names>C</given-names></name><name><surname>Dietrich</surname><given-names>M</given-names></name><name><surname>Norkus</surname><given-names>EP</given-names></name><name><surname>Hudes</surname><given-names>M</given-names></name><name><surname>Packer</surname><given-names>L</given-names></name></person-group><article-title>Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation.</article-title><source>J Am Coll Nutr.</source><year>2004</year><volume>23</volume><issue>2</issue><fpage>141</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15047680</pub-id></element-citation></ref><ref id="A13351R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gholipour</surname><given-names>A</given-names></name><name><surname>Emami</surname><given-names>A</given-names></name><name><surname>Khademloo</surname><given-names>M</given-names></name><name><surname>Naghshvar</surname><given-names>F</given-names></name><name><surname>Razavi</surname><given-names>M</given-names></name><name><surname>Espahbodi</surname><given-names>F</given-names></name></person-group><article-title>The Effect of Intravenous Vitamin C on the Level of CRP in Hemodialysis Patients.</article-title><source>J Mazand Univ Med Sci.</source><year>2011</year><volume>21</volume><issue>80</issue><fpage>55</fpage><lpage>61</lpage></element-citation></ref><ref id="A13351R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumeron</surname><given-names>C</given-names></name><name><surname>Nguyen-Khoa</surname><given-names>T</given-names></name><name><surname>Saltiel</surname><given-names>C</given-names></name><name><surname>Kebede</surname><given-names>M</given-names></name><name><surname>Buisson</surname><given-names>C</given-names></name><name><surname>Drueke</surname><given-names>TB</given-names></name><etal>et al.</etal></person-group><article-title>Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.</article-title><source>Nephrol Dial Transplant.</source><year>2005</year><volume>20</volume><issue>9</issue><fpage>1874</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfh928</pub-id><pub-id pub-id-type="pmid">15972322</pub-id></element-citation></ref><ref id="A13351R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padayatty</surname><given-names>SJ</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Riordan</surname><given-names>HD</given-names></name><name><surname>Hewitt</surname><given-names>SM</given-names></name><name><surname>Katz</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Vitamin C pharmacokinetics: implications for oral and intravenous use.</article-title><source>Ann Intern Med.</source><year>2004</year><volume>140</volume><issue>7</issue><fpage>533</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15068981</pub-id></element-citation></ref><ref id="A13351R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massy</surname><given-names>ZA</given-names></name><name><surname>Nguyen-Khoa</surname><given-names>T</given-names></name></person-group><article-title>Oxidative stress and chronic renal failure: markers and management.</article-title><source>J Nephrol.</source><year>2002</year><volume>15</volume><issue>4</issue><fpage>336</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">12243361</pub-id></element-citation></ref><ref id="A13351R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helal</surname><given-names>I</given-names></name><name><surname>Zerelli</surname><given-names>L</given-names></name><name><surname>Krid</surname><given-names>M</given-names></name><name><surname>ElYounsi</surname><given-names>F</given-names></name><name><surname>Ben Maiz</surname><given-names>H</given-names></name><name><surname>Zouari</surname><given-names>B</given-names></name><etal>et al.</etal></person-group><article-title>Comparison of C-reactive protein and high-sensitivity C-reactive protein levels in patients on hemodialysis.</article-title><source>Saudi J Kidney Dis Transpl.</source><year>2012</year><volume>23</volume><issue>3</issue><fpage>477</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">22569431</pub-id></element-citation></ref><ref id="A13351R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locatelli</surname><given-names>F</given-names></name><name><surname>Canaud</surname><given-names>B</given-names></name><name><surname>Eckardt</surname><given-names>KU</given-names></name><name><surname>Stenvinkel</surname><given-names>P</given-names></name><name><surname>Wanner</surname><given-names>C</given-names></name><name><surname>Zoccali</surname><given-names>C</given-names></name></person-group><article-title>Oxidative stress in end-stage renal disease: an emerging threat to patient outcome.</article-title><source>Nephrol Dial Transplant.</source><year>2003</year><volume>18</volume><issue>7</issue><fpage>1272</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">12808161</pub-id></element-citation></ref><ref id="A13351R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sezer</surname><given-names>S</given-names></name><name><surname>Ozdemir</surname><given-names>FN</given-names></name><name><surname>Yakupoglu</surname><given-names>U</given-names></name><name><surname>Arat</surname><given-names>Z</given-names></name><name><surname>Turan</surname><given-names>M</given-names></name><name><surname>Haberal</surname><given-names>M</given-names></name></person-group><article-title>Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients.</article-title><source>Artif Organs.</source><year>2002</year><volume>26</volume><issue>4</issue><fpage>366</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11952508</pub-id></element-citation></ref><ref id="A13351R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohm</surname><given-names>V</given-names></name><name><surname>Tiroke</surname><given-names>K</given-names></name><name><surname>Schneider</surname><given-names>S</given-names></name><name><surname>Sperschneider</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>G</given-names></name><name><surname>Bitsch</surname><given-names>R</given-names></name></person-group><article-title>Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.</article-title><source>Int J Vitam Nutr Res.</source><year>1997</year><volume>67</volume><issue>4</issue><fpage>262</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9285256</pub-id></element-citation></ref><ref id="A13351R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durose</surname><given-names>CL</given-names></name><name><surname>Holdsworth</surname><given-names>M</given-names></name><name><surname>Watson</surname><given-names>V</given-names></name><name><surname>Przygrodzka</surname><given-names>F</given-names></name></person-group><article-title>Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance.</article-title><source>J Am Diet Assoc.</source><year>2004</year><volume>104</volume><issue>1</issue><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.jada.2003.10.016</pub-id><pub-id pub-id-type="pmid">14702581</pub-id></element-citation></ref><ref id="A13351R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morena</surname><given-names>M</given-names></name><name><surname>Cristol</surname><given-names>JP</given-names></name><name><surname>Bosc</surname><given-names>JY</given-names></name><name><surname>Tetta</surname><given-names>C</given-names></name><name><surname>Forret</surname><given-names>G</given-names></name><name><surname>Leger</surname><given-names>CL</given-names></name><etal>et al.</etal></person-group><article-title>Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients.</article-title><source>Nephrol Dial Transplant.</source><year>2002</year><volume>17</volume><issue>3</issue><fpage>422</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11865087</pub-id></element-citation></ref><ref id="A13351R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handelman</surname><given-names>GJ</given-names></name></person-group><article-title>Vitamin C deficiency in dialysis patients--are we perceiving the tip of an iceberg?</article-title><source>Nephrol Dial Transplant.</source><year>2007</year><volume>22</volume><issue>2</issue><fpage>328</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfl534</pub-id><pub-id pub-id-type="pmid">17107966</pub-id></element-citation></ref><ref id="A13351R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>A</given-names></name><name><surname>Kuhlmann</surname><given-names>MK</given-names></name><name><surname>Seibert</surname><given-names>E</given-names></name><name><surname>Kotanko</surname><given-names>P</given-names></name><name><surname>Levin</surname><given-names>NW</given-names></name><name><surname>Handelman</surname><given-names>GJ</given-names></name></person-group><article-title>Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients.</article-title><source>Nephrol Dial Transplant.</source><year>2008</year><volume>23</volume><issue>6</issue><fpage>2058</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfn084</pub-id><pub-id pub-id-type="pmid">18353890</pub-id></element-citation></ref><ref id="A13351R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Moriyama</surname><given-names>Y</given-names></name><name><surname>Yamagishi</surname><given-names>K</given-names></name><name><surname>Tanigawa</surname><given-names>T</given-names></name><name><surname>Noda</surname><given-names>H</given-names></name><name><surname>Yokota</surname><given-names>K</given-names></name><etal>et al.</etal></person-group><article-title>Serum vitamin C concentration and hs-CRP level in middle-aged Japanese men and women.</article-title><source>Atherosclerosis.</source><year>2010</year><volume>208</volume><issue>2</issue><fpage>496</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2009.07.052</pub-id><pub-id pub-id-type="pmid">19717151</pub-id></element-citation></ref><ref id="A13351R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>A</given-names></name><name><surname>Rodriguez-Artalejo</surname><given-names>F</given-names></name><name><surname>Lopes</surname><given-names>C</given-names></name></person-group><article-title>The association of fruits, vegetables, antioxidant vitamins and fibre intake with high-sensitivity C-reactive protein: sex and body mass index interactions.</article-title><source>Eur J Clin Nutr.</source><year>2009</year><volume>63</volume><issue>11</issue><fpage>1345</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1038/ejcn.2009.61</pub-id><pub-id pub-id-type="pmid">19623199</pub-id></element-citation></ref></ref-list></back></article>